Neuroprotective Effects of Peptides during Ischemic Preconditioning.
Zarubina. I V IV; Shabanov. P D PD
Key Findings
- Cortagen reduced neurological deficits in rats undergoing chronic brain ischemia.
- The peptide helped restore normal individual behavior despite different levels of hypoxia tolerance.
- It showed antioxidant activity during both early and late phases of ischemic preconditioning.
Practical Outcomes
- The study suggests cortagen may have neuroprotective properties, but it is limited to animal models with no human dosing or safety data. For biohackers, the finding is interesting but not ready for direct use; more research is needed before considering supplementation for brain health or ischemic protection.
Summary
In rats, a brain‑specific protein mix called cortagen helped protect the brain from damage caused by repeated low‑oxygen events. It lowered the severity of neurological problems, improved the animals' normal behavior, and acted as an antioxidant during both early and later stages of the damage process.
Abstract
Experiments on rats showed that neurospecific protein preparations reduce the severity of neurological deficit, restore the structure of individual behavior of the animals with different hypoxia tolerance, and exert antioxidant action during chronic ischemic damage to the brain unfolding during the early and late phases of ischemic preconditioning.
Study Information
pubmed
2016
2016-02-23T00:00:00.000Z
10.1007/s10517-016-3193-9